Bartec Technologies

Farnborough, United Kingdom Founded: 1998 • Age: 28 yrs Acquired By Mediso
Mediso: Advanced medical imaging systems and radioactive sources

About Bartec Technologies

Bartec Technologies is a Healthcare company based in Farnborough (United Kingdom) founded in 1998, and was acquired by Mediso in May 2022. Mediso: Advanced medical imaging systems and radioactive sources. Bartec Technologies offers products and services including AnyScan® TRIO SPECT/CT, nanoScan® PET/MRI, nanoScan® SPECT/CT, and nanoScan® PET/CT. Its focus areas include Pharmaceutical Distributors and Specialty Drugs. Its legal entity is MEDISO MEDICAL IMAGING SYSTEMS UK LIMITED. Its competitors include CNX Therapeutics, Xiel and SPL Pharma.

Company details

Founded in 1998 and based in Farnborough, United Kingdom, Bartec Technologies operates in the medical imaging sector. Clinical and preclinical molecular imaging systems are provided, along with modality-specific detectors for nuclear medicine applications. Radioactive sources, including flood sources and phantoms, are offered for quality control. Radiation protection services, such as lead-lined shielding, are also supplied to support healthcare environments. Operations focus on diagnostic and therapeutic tools across various institutions.

  • Headquarters Farnborough, United Kingdom
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website bartectechnologies.com
  • Social LinkedIn X
  • Acquired by Mediso (May 2022)
  • Legal Name Mediso Medical Imaging Systems Uk Limited
  • Date of Incorporation 17 Aug, 1998
  • Jurisdiction FARNBOROUGH, HAMPSHIRE, ENGLAND
Key Metrics

Products & Services of Bartec Technologies

Bartec Technologies offers a comprehensive portfolio of products and services, including AnyScan® TRIO SPECT/CT, nanoScan® PET/MRI, nanoScan® SPECT/CT, and nanoScan® PET/CT.

AnyScan® TRIO SPECT/CT
Medical Imaging System

SPECT/CT for theragnostic and diagnostic imaging in clinical settings

nanoScan® PET/MRI
Medical Imaging System

PET/MRI for quantitative preclinical research and molecular imaging

nanoScan® SPECT/CT
Medical Imaging System

SPECT/CT for absolute quantification in preclinical applications

nanoScan® PET/CT
Medical Imaging System

PET/CT for real dynamic studies in research environments

Investors in Bartec Technologies

Bartec Technologies has secured backing from 1 investor. Prominent investors backing the company include Mediso.

All
InvestorDescriptionFounded YearDomainLocation
Nuclear medicine and hybrid imaging equipment
1990mediso.comBudapest, Hungary
Premium access

Investor details for Bartec Technologies

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Bartec Technologies

1 people are tracked at Bartec Technologies (1 in leadership).

NameRoleGroup
Grahame McCracken
Managing DirectorLeadership
Premium access

Complete people profiles for Bartec Technologies

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Bartec Technologies

2 dated milestones of Bartec Technologies across 24 years, from founding to its latest funding, stage changes and deals.

  1. Founded Bartec Technologies is founded.
  2. Exit Acquired by Mediso.

Competitors of Bartec Technologies

Bartec Technologies has 3 listed competitors in our database. They include CNX Therapeutics, Xiel and SPL Pharma.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cnx-therapeutics.com2021London, United Kingdom
Distributor of specialty drugs
xiel.co.uk2019Somerset, United Kingdom
Specialist nuclear medicine and radiotherapy solutions are distributed.
splpharma.co.uk2016London, United Kingdom
International distribution of specialty medicines and pharmaceutical market access services.
Premium access

Detailed competitors of Bartec Technologies

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Bartec Technologies

Websites that share an audience with Bartec Technologies (bartectechnologies.com).

Similar websites

Websites whose visitors overlap most with Bartec Technologies. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
google.com
100%
85.8B#1View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • âś“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • âś“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • âś“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Bartec Technologies

Bartec Technologies was founded in 1998.

Bartec Technologies is headquartered in Farnborough, United Kingdom. It is registered at Farnborough, Hampshire, United Kingdom.

Founded in 1998 and based in Farnborough, United Kingdom, Bartec Technologies operates in the medical imaging sector. Clinical and preclinical molecular imaging systems are provided, along with modality-specific detectors for nuclear medicine applications. Radioactive sources, including flood sources and phantoms, are offered for quality control. Radiation protection services, such as lead-lined shielding, are also supplied to support healthcare environments. Operations focus on diagnostic and therapeutic tools across various institutions.

Bartec Technologies's top competitors include Xiel, CNX Therapeutics and SPL Pharma.

Bartec Technologies offers AnyScan® TRIO SPECT/CT, nanoScan® PET/MRI, nanoScan® SPECT/CT, and nanoScan® PET/CT.

Bartec Technologies has 1 investor. Key investors include Mediso.

Bartec Technologies operates through Mediso Medical Imaging Systems Uk Limited.

Yes. Bartec Technologies was acquired by Mediso in May 2022.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available